Small Proline Rich Protein 2A (SPRR2A) (N-Term) Peptide
SPRR2A
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits SPRR2A
- SPRR2A (Small Proline Rich Protein 2A (SPRR2A))
- Protein Region
- N-Term
- Origine
- Humain
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- CPEPCPPPKC PEPCPPPKCP QPCPPQQCQQ KYPPVTPSPP CQSKYPPKSK
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SPRR2A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- SPRR2A (Small Proline Rich Protein 2A (SPRR2A))
- Synonymes
- SPRR2A Peptide, Sprr2a Peptide, small proline-rich protein 2A Peptide, small proline rich protein 2A Peptide, small proline-rich protein 2A1 Peptide, SPRR2A Peptide, Sprr2a1 Peptide
- Sujet
-
SPRR2A is a cross-linked envelope protein of keratinocytes. It is a keratinocyte protein that first appears in the cell cytosol, but ultimately becomes cross-linked to membrane proteins by transglutaminase. All that results in the formation of an insoluble envelope beneath the plasma membrane.
Alias Symbols: -
Protein Interaction Partner: EVPL
Protein Size: 72 - Poids moléculaire
- 8 kDa
- ID gène
- 6700
- NCBI Accession
- NM_005988, NP_005979
- UniProt
- P35326
-
Vous êtes ici:
